We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
- Authors
Hirano, Toru; Ohguro, Nobuyuki; Hohki, Satoshi; Hagihara, Keisuke; Shima, Yoshihito; Narazaki, Masashi; Ogata, Atsushi; Yoshizaki, Kazuyuki; Kumanogoh, Atsushi; Kishimoto, Tadamitsu; Tanaka, Toshio
- Abstract
A 47-year-old female patient with Behçet's disease had been treated with colchicine, prednisolone, cyclosporine A, and infliximab. Because she relapsed, however, treatment with tocilizumab, a humanized anti-interleukin 6 receptor antibody, was started. This treatment suppressed the patient's clinical manifestations, including ocular attacks, for 1 year and improved her visual acuity. This experience indicates that tocilizumab may constitute a therapeutic option for refractory Behçet's disease.
- Subjects
COLCHICINE; INFLIXIMAB; RHEUMATOID arthritis treatment; INTERLEUKIN-6 receptors; DISEASE relapse; IMMUNOGLOBULINS; VISUAL acuity
- Publication
Modern Rheumatology, 2012, Vol 22, Issue 2, p298
- ISSN
1439-7595
- Publication type
Article
- DOI
10.3109/s10165-011-0497-5